Satsuma Pharmaceuticals, Inc. announced the appointment of Mutya Harsch, JD to its Board of Directors, effective October 12, 2021. Ms. Harsch currently serves as General Counsel, Chief Legal Officer and Secretary of VYNE Therapeutics, a publicly traded biopharmaceutical company.